Jallal Bahija
SEC CIK 1730038 · EDGAR
BoughtSold
Most active insiders at ELV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BOUDREAUX GAIL | Pres, CEO, Dir | $1.00M | — |
| 2 | Kendrick Charles Morgan JR | EVP, Pres, Commercial | — | $910.6K |
| 3 | COLLIS STEVEN H | Dir | $869.5K | — |
| 4 | Penczek Ronald W | CAO, Ctrl | — | $766.0K |
| 5 | PERU RAMIRO G | Dir | $366.1K | — |
| 6 | Dixon Robert L JR | Dir | — | $60.7K |
| 7 | SCHULMAN AMY W | Dir | — | $7,475 |
| 8 | Wessling Erin M | EVP, CLO | — | — |
| 9 | Craig Ryan R | EVP, Chief HR Off | — | — |
| 10 | Kaye Mark | EVP, CFO | — | — |
| 13 | Jallal Bahija | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 16:14 | 2026-05-13 | ELV | Elevance Health | Jallal Bahija | Dir | A - Grant | $0.00 | +563 | 5,351 | +12% | $0 | |
| D | 2026-02-19 | 2026-02-18 | IMCR | Immunocore Holdings plc | Jallal Bahija | CEO, Dir | S - Sale+OE | $32.35 | -11.5K | 12.3K | -48% | -$371.2K |
| D | 2026-02-19 | 2026-02-17 | IMCR | Immunocore Holdings plc | Jallal Bahija | CEO, Dir | M - OptEx | $0.00 | +23.8K | 23.8K | New | $0 |
| 2025-05-16 | 2025-05-14 | ELV | Elevance Health | Jallal Bahija | Dir | A - Grant | $0.00 | +601 | 4,788 | +14% | $0 | |
| 2024-05-17 | 2024-05-15 | ELV | Elevance Health | Jallal Bahija | Dir | A - Grant | $0.00 | +388 | 4,187 | +10% | $0 | |
| 2023-05-12 | 2023-05-10 | ELV | Elevance Health | Jallal Bahija | Dir | A - Grant | $0.00 | +457 | 3,799 | +14% | $0 | |
| D | 2022-06-17 | 2022-06-15 | GH | Guardant Health, Inc. | Jallal Bahija | Dir | M - OptEx | $0.00 | +1,814 | 7,408 | +32% | $0 |
| 2022-05-20 | 2022-05-18 | ELV | Elevance Health | Jallal Bahija | Dir | A - Grant | $0.00 | +440 | 3,342 | +15% | $0 |
Purchase Sale Sale after option exercise All abbreviations